Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
REMEVi review
An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.
- Semaglutide
- $199/mo
- Tirzepatide
- $269/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The Luna Fit scorecard
REMEVi scored on our six women's-health factors. See the methodology.
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
The bottom line
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.
Ranked #32 of 80 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Price transparency is where REMEVi scores lowest, at 82/100. If that is your sticking point, start with the REMEVi alternatives, scored on the same six factors.
Others in REMEVi's score range
The providers scoring closest to REMEVi on the same six factors. One of those comparisons is written out in full: the REMEVi–CoreAge Rx head-to-head, 8 points apart on the Luna Fit Score. Directly below REMEVi sits NiceRx at #33 with 85/100 — see the alternatives to NiceRx we rank for women if that is the band you are shopping in.
See all 80 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect REMEVi's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.